Mahin Lashkari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahin Lashkari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Sonia Oveisi
M.D., MPH, Ph.D. of Maternal and Child Health, Associate Professor, Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
3 shared publications- Akram Noori
Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
2 shared publications Akram Noori
M.D., Rheumatologist, Assistant Professor, Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication- Ali Zargar
Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication - Amir Mohammad Kazemifar
Department of Clinical Toxicology, Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication Fatemeh Hajiimanouchehri
Pathology Department, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication
Latest Publications
- Open Access
- 25 March 2018
- Published by Knowledge Kingdom Publishing in Electronic Physiciane
- Vol. 10 (3) , 6500-6505
Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study
Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study
- 25 March 2018
- Published by Knowledge Kingdom Publishing in Electronic Physiciane
- Vol. 10 (3) , 6500-6505
Open AccessAssociation of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study
Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study
- Open Access
- 25 June 2014
- Published by Canadian Center of Science and Education in Global Journal of Health Science
- Vol. 6 (6) , p82-7
Assessment of Vitamin K2 Levels in Osteoporotic Patients: A Case Control Study
Objective: The aim of this study was to measure the level of Vitamin K2 (Vit K2) in osteoporotic patients and individuals with normal bone density as controls. Materials and Methods: This case-control study was done in Outpatient Department of Rheumatology at Qazvin Boo-ali Sina Hospital in 2013. Participants were 50 patients with osteoporotic densitometry measured by DEXA (T score? -2.5) who were matched with 48 persons in control group with normal bone density (T score> -1). The level of Vit K2 in samples was measured using enzyme linked immunosorbent assay (ELISA). Data were analyzed by Mann-Whitney U test and Chi-square test. Results: The level of Vit K2 in patients with osteoporosis was not significantly different from the control group (Median: 75.95 vs. 71.35 nmol/L, respectively; P-value: 0.709). The authors determined cut-offs 75 percentile of vitamin K2 in all participants that was 85 nmol/L and percentages of persons in two groups were similar. Conclusion: Although Vit K2 level in patients with osteoporosis was not significantly different from the control group, further studies are necessary to confirm the association of osteoporosis and Vit K2.
- 25 June 2014
- Published by Canadian Center of Science and Education in Global Journal of Health Science
- Vol. 6 (6) , p82-7
Open AccessAssessment of Vitamin K2 Levels in Osteoporotic Patients: A Case Control Study
Objective: The aim of this study was to measure the level of Vitamin K2 (Vit K2) in osteoporotic patients and individuals with normal bone density as controls. Materials and Methods: This case-control study was done in Outpatient Department of Rheumatology at Qazvin Boo-ali Sina Hospital in 2013. Participants were 50 patients with osteoporotic densitometry measured by DEXA (T score? -2.5) who were matched with 48 persons in control group with normal bone density (T score> -1). The level of Vit K2 in samples was measured using enzyme linked immunosorbent assay (ELISA). Data were analyzed by Mann-Whitney U test and Chi-square test. Results: The level of Vit K2 in patients with osteoporosis was not significantly different from the control group (Median: 75.95 vs. 71.35 nmol/L, respectively; P-value: 0.709). The authors determined cut-offs 75 percentile of vitamin K2 in all participants that was 85 nmol/L and percentages of persons in two groups were similar. Conclusion: Although Vit K2 level in patients with osteoporosis was not significantly different from the control group, further studies are necessary to confirm the association of osteoporosis and Vit K2.
- Open Access
- 17 March 2014
- Published by Canadian Center of Science and Education in Global Journal of Health Science
- Vol. 6 (4) , p292-7
Determination of specificity and sensitivity of Anti-RA 33 in diagnosis of early Rheumatoid arthritis
Background: Rheumatoid arthritis is a chronic inflammatory disease with uncertain etiology characterized by symmetric polyarthritis in peripheral joints. Its diagnosis is based on clinical findings and serologic tests. They are rarely conclusive in early course of the disease. So, its early diagnosis could be difficult. The present study was designed to evaluate the role of Anti -RA33; an Auto-Antibody against RA33 in early diagnosis of the disease. Material and methods: forty three patients who had been visited in a Rheumatology Clinic were randomly selected. Their disease has been diagnosed by a Rheumatologist. 55 persons were chosen from healthy individuals who had attended in other clinic. Their age and sex were matched with the case group. Anti-RA33 and RF titers were measured in their blood sample using standard methods. Findings: RF and Anti-RA33 titers had significant correlation in case group (p=0.015). Anti -RA33 test had 98% sensitivity, 20% specificity, 55% positive predictive value, and 90% negative predictive. Conclusion: Anti -RA33 could have diagnostic and prognostic value in diagnosis and evaluation of patients with RA, and its differentiation from other small joint disorders, particularly when the other serologic tests are negative.
- 17 March 2014
- Published by Canadian Center of Science and Education in Global Journal of Health Science
- Vol. 6 (4) , p292-7
Open AccessDetermination of specificity and sensitivity of Anti-RA 33 in diagnosis of early Rheumatoid arthritis
Background: Rheumatoid arthritis is a chronic inflammatory disease with uncertain etiology characterized by symmetric polyarthritis in peripheral joints. Its diagnosis is based on clinical findings and serologic tests. They are rarely conclusive in early course of the disease. So, its early diagnosis could be difficult. The present study was designed to evaluate the role of Anti -RA33; an Auto-Antibody against RA33 in early diagnosis of the disease. Material and methods: forty three patients who had been visited in a Rheumatology Clinic were randomly selected. Their disease has been diagnosed by a Rheumatologist. 55 persons were chosen from healthy individuals who had attended in other clinic. Their age and sex were matched with the case group. Anti-RA33 and RF titers were measured in their blood sample using standard methods. Findings: RF and Anti-RA33 titers had significant correlation in case group (p=0.015). Anti -RA33 test had 98% sensitivity, 20% specificity, 55% positive predictive value, and 90% negative predictive. Conclusion: Anti -RA33 could have diagnostic and prognostic value in diagnosis and evaluation of patients with RA, and its differentiation from other small joint disorders, particularly when the other serologic tests are negative.